Why Did Warren Buffett Buy Amazon Stock?
When investors think of tech stocks in Warren Buffett’s portfolio,…
Sell
30
FG Quote, Financials, Valuation and Earnings
Last price:
$32.24
Seasonality move
:
23.06%
Day range:
$31.16 - $32.07
52-week range:
$30.10 - $50.75
Dividend yield:
2.71%
P/E ratio:
8.51x
P/S ratio:
0.86x
P/B ratio:
0.99x
Volume:
147.8K
Avg. volume:
211.9K
1-year change:
-16.77%
Market cap:
$4.3B
Revenue:
$5.4B
EPS (TTM):
$3.77
Analysts' Opinion
-
Consensus RatingF&G Annuities & Life has received a consensus rating of Hold. The company's average rating is a Hold based on 0 Buy ratings, 2 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $37.00, F&G Annuities & Life has an estimated upside of 15.37% from its current price of $32.07.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $34.00 representing 100% downside risk from its current price of $32.07.
Fair Value
-
According to the consensus of 2 analysts, F&G Annuities & Life has 15.37% upside to fair value with a price target of $37.00 per share.
FG vs. S&P 500
-
Over the past 5 trading days, F&G Annuities & Life has overperformed the S&P 500 by 1.83% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
F&G Annuities & Life does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
F&G Annuities & Life revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter F&G Annuities & Life reported revenues of $854M.
Earnings Growth
-
F&G Annuities & Life has grown year-over-year earnings for 1 quarter straight. In the most recent quarter F&G Annuities & Life reported earnings per share of -$0.20.
Enterprise value:
-21.9B
EV / Invested capital:
-3.25x
Price / LTM sales:
0.86x
EV / EBIT:
-29.07x
EV / Revenue:
-4.59x
PEG ratio (5yr expected):
0.09x
EV / Free cash flow:
-4.05x
Price / Operating cash flow:
0.76x
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
0.61%
Net Income Margin (TTM):
10.57%
Return On Equity:
12.26%
Return On Invested Capital:
8.18%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Income Statement | ||||||
| Revenue | $2.4B | $5B | $4.8B | $1.5B | $854M | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | $27.42 | $1.96 | $3.77 | $0.88 | -$0.20 | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $43.4B | $36.5B | $44B | |
| Total Assets | -- | -- | $59.4B | $74.4B | $88B | |
| Current Liabilities | -- | -- | $851M | $1.4B | $1.2B | |
| Total Liabilities | -- | -- | $56.9B | $70.8B | $83.5B | |
| Total Equity | -- | -- | $2.5B | $3.7B | $4.5B | |
| Total Debt | -- | -- | $1.6B | $1.7B | $2.2B | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-03-31 | 2024-03-31 | 2025-03-31 | 2024-03-31 | 2025-03-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $4.2B | $5.9B | $5.4B | $1.5B | $956M | |
| Cash From Investing | -$9.6B | -$7.9B | -$7.4B | -$1.4B | -$809M | |
| Cash From Financing | $5.8B | $2.8B | $2.9B | $659M | $882M | |
| Free Cash Flow | $4.2B | $5.9B | $5.4B | $1.5B | $951M | |
FG
Sector
Market Cap
$4.3B
$620M
Price % of 52-Week High
63.19%
86.64%
Dividend Yield
2.71%
2.06%
Shareholder Yield
-4.95%
4.11%
1-Year Price Total Return
-16.77%
11.29%
Beta (5-Year)
--
0.594
Dividend yield:
2.71%
Annualized payout:
$0.85
Payout ratio:
24.85%
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$31.84
200-day SMA
Sell
Level
$40.20
Bollinger Bands (100)
Sell
Level
31.92 - 42.2
Chaikin Money Flow
Sell
Level
-915.3K
20-day SMA
Sell
Level
$32.08
Relative Strength Index (RSI14)
Sell
Level
47.93
ADX Line
Sell
Level
17.35
Williams %R
Neutral
Level
-58.0524
50-day SMA
Sell
Level
$32.97
MACD (12, 26)
Sell
Level
-0.37
25-day Aroon Oscillator
Sell
Level
-28
On Balance Volume
Sell
Level
-1.6M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.7693)
Sell
CA Score
(Annual)
Level (-2.4726)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (4)
Buy
Ohlson Score
Level (0.26)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.
Stock Forecast FAQ
In the current month, FG has received 0 Buy ratings 2 Hold ratings, and 0 Sell ratings. The FG average analyst price target in the past 3 months is $37.00.
-
Where Will F&G Annuities & Life Stock Be In 1 Year?
According to analysts, the consensus estimate is that F&G Annuities & Life share price will rise to $37.00 per share over the next 12 months.
-
What Do Analysts Say About F&G Annuities & Life?
Analysts are divided on their view about F&G Annuities & Life share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that F&G Annuities & Life is a Sell and believe this share price will drop from its current level to $34.00.
-
What Is F&G Annuities & Life's Price Target?
The price target for F&G Annuities & Life over the next 1-year time period is forecast to be $37.00 according to 2 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 2 analysts rate the stock a Hold.
-
Is FG A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for F&G Annuities & Life is a Hold. 2 of 2 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of FG?
You can purchase shares of F&G Annuities & Life via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase F&G Annuities & Life shares.
-
What Is The F&G Annuities & Life Share Price Today?
F&G Annuities & Life was last trading at $32.24 per share. This represents the most recent stock quote for F&G Annuities & Life. Yesterday, F&G Annuities & Life closed at $32.07 per share.
-
How To Buy F&G Annuities & Life Stock Online?
In order to purchase F&G Annuities & Life stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Where Will RocketLab Stock Be In 5 Years?
Rocket Lab (NASDAQ: RKLB) closed recently at around $30 per share,…
Is MO dividend Worth It?
Altria Group (NYSE: MO) is paying investors $1.02 a share…
Stock Ideas
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.6T
P/E Ratio: 41x
Buy
59
Is NVDA Stock a Buy?
Market Cap: $3.5T
P/E Ratio: 49x
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
88
CDTX alert for Jun 24
Cidara Therapeutics [CDTX] is down 0.04% over the past day.
Sell
46
HIMS alert for Jun 24
Hims & Hers Health [HIMS] is up 1.93% over the past day.
Buy
67
WGS alert for Jun 24
GeneDx Holdings [WGS] is up 11.94% over the past day.
